Rapid immunodiagnosis of tuberculosis in a woman receiving anti-TNF therapy (Q40440524)

20 September 2017

Rapid immunodiagnosis of tuberculosis in a woman receiving anti-TNF therapy (English)

1 reference

20 September 2017

0 references

0 references

Christoph Lange

1

0 references

author name string

Bernhard Hellmich

series ordinal

2

1 reference

PubMed ID

17762852

20 September 2017

Martin Ernst

series ordinal

3

1 reference

PubMed ID

17762852

20 September 2017

Stefan Ehlers

series ordinal

4

1 reference

20 September 2017

1 September 2007

1 reference

Nature Clinical Practice Rheumatology

20 September 2017

1 reference

20 September 2017

3

1 reference

20 September 2017

9

1 reference

20 September 2017

528-534

1 reference

Early diagnosis of subclinical multidrug-resistant tuberculosis.

20 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

The immunological aspects of latency in tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Disseminated tuberculosis after anti-TNFalpha treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Impact of a T cell-based blood test for tuberculosis infection on clinical decision-making in routine practice

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Ex Vivo Characterization of Early Secretory Antigenic Target 6-Specific T Cells at Sites of Active Disease in Pleural Tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Reactivation of latent granulomatous infections by infliximab

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0571

7 January 2021

Identifiers

DOI

10.1038/NCPRHEUM0571

1 reference

20 September 2017

1 reference

PubMed ID

17762852